UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 27,801 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 10.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 237,409 shares of the biopharmaceutical company’s stock after selling […]
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 10.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 237,409 shares of the biopharmaceutical company’s stock after selling […]
